Pidotimod for the prevention of acute respiratory infections in healthy children entering into daycare: A double blind randomized placebo-controlled study

Pharmacological Research

Volumn 97, Issue , 2015, Pages 79-83

  Mameli, Chiara ^a   Pasinato, Angela ^b   Picca, Marina ^c   Bedogni, Giorgio ^d   Pisanelli, Stefania ^e   Zuccotti, Gian Vincenzo ^a   Bollani, Tiziana ^f   Decarlis, Silvia ^f   Dozzi, Massimiliano ^f   Nicolettafaggian, N ^f   Giovannniello, Antonella ^f   Mezzopane, Angela ^f   Pia Centini, Elena ^f   Pittarello, Daniele ^f   Ronconi, Massimo ^f   Ruffato, Bruno ^f   Mirellascarazatti, M ^f   Spanevello, Valter ^f   Vettori, Valeria ^f   Zuffellato, Vittorio ^f  

^a UNIVERSITY OF MILAN   (Italy)

^b Center for Research and Education of Family Pediatricians (CESPER)   (Italy)

^c Pediatric Society of Primary Health Care (SICuPP)   (Italy)

^d Liver Research Center   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f NONE

Author keywords

Children; Immunostimulant; Kindergarten; Pidotimod; Respiratory infections

Indexed keywords

ANTIBIOTIC AGENT; PIDOTIMOD; PLACEBO; IMMUNOLOGICAL ADJUVANT; PYROGLUTAMIC ACID; THIAZOLIDINE DERIVATIVE;

ARTICLE; CHILD; CHILD CARE; CONTROLLED STUDY; DAY CARE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEVER; FOLLOW UP; HUMAN; INCIDENCE; INFECTION PREVENTION; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; URTICARIA; ACUTE DISEASE; ANALOGS AND DERIVATIVES; FEMALE; IMMUNIZATION; INFANT; MALE; RESPIRATORY TRACT INFECTIONS; RISK REDUCTION; TREATMENT OUTCOME;

ACUTE DISEASE; ADJUVANTS, IMMUNOLOGIC; CHILD DAY CARE CENTERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNIZATION; INCIDENCE; INFANT; MALE; PYRROLIDONECARBOXYLIC ACID; RESPIRATORY TRACT INFECTIONS; RISK REDUCTION BEHAVIOR; THIAZOLIDINES; TREATMENT OUTCOME;

EID: 84928987235     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.04.007     Document Type: Article

References (25)

1. M. De Martino, and S. Ballotti The child with recurrent respiratory infections: normal or not? Pediatr. Allergy Immunol. 18 2007 13 18
2. P. Nafstad, J.A. Hagen, L. Oie, P. Magnus, and J.J. Jaakkola Day care centers and respiratory health Pediatrics 103 1999 753 758
3. V.R. Dharnidharka, P. Fiorina, and W.E. Harmon Kidney transplantation in children N. Engl. J. Med. 371 2014 549 558
4. G. Karevold, E. Kvestad, P. Nafstad, and K.J. Kvaerner Respiratory infections in schoolchildren: co-morbidity and risk factors Arch. Dis. Child. 91 2006 391 395
5. G. Forssel, A. Hakansson, and N.O. Mansson Risk factors for respiratory tract infections in children aged 2-5 years Scand. J. Prim. Health Care 19 2001 122 125
6. Y. Zhang, M. Xu, J. Zhang, L. Zeng, Y. Wang, and Q.Y. Zheng Risk factors for chronic and recurrent otitis media - a meta-analysis PLoS ONE 2014 10.1371/journal.pone.0086397
7. J.G. Wheeler Evaluating the child with recurrent infections Am. Fam. Phys. 54 1996 2276 2282
8. A.C. Van de Pol, A.C. van der Gugten, C.K. van der Ent, A.G. Schilder, E.M. Benthem, and H.A. Smit Referrals for recurrent respiratory tract infections including otitis media in young children Int. J. Pediatr. Otorhinolaryngol. 77 2013 906 910
9. B.E. Del Rio Navarro, F. Espinosa Rosales, V. Flenady, and J.J. Sienra Monge Immunostimulants for preventing respiratory tract infection in children Cochrane Database Syst. Rev. 4 2006 CD004974
10. H. McCutcheon, and M. Fitzgerald The public health problem of acute respiratory illness in childcare J. Clin. Nurs. 10 2001 305 310
11. G.V. Zuccotti, and C. Mameli Pidotimod: the past and the present Ital. J. Pediatr. 39 2013 75
12. P. Riboldi, M. Gerosa, and P.L. Meroni Pidotimod: a reappraisal Int. J. Immunopathol. Pharmacol. 22 2009 255 262
13. G. Migliorati, L. D'Adamio, G. Coppi, I. Nicoletti, and C. Riccardi Pidotimod stimulates natural killer cell activity and inhibits thymocyte cell death Immunopharmacol. Immunotoxicol. 14 1992 737 748
14. A. Auteri, A.L. Pasqui, F. Bruni, M. Saletti, M. Di Renzo, and G. Bova Effect of Pidotimod, a new immunostimulating agent, on some aspects of immune response. In vitro study Pharmacol. Res. 26 S 1992 196 197
15. C. Giagulli, M. Noerder, M. Avolio, P.D. Becker, S. Fiorentini, and C.A. Guzman Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level Int. Immunopharmacol. 9 2009 1366 1373
16. G.V. Zuccotti, C. Mameli, D. Trabattoni, S. Beretta, M. Biasin, and L. Guazzarotti Immunomodulating activity of pidotimod in children with Down syndrome J. Biol. Regul. Homeost. Agents 27 2013 253 258
17. L.S. Namazova-Baranova, A.A. Alekseeva, S.M. Kharit, T.N. Kozhevnikova, T.E. Taranushenko, and I.A. Tuzankina Efficacy and safety of pidotimod in the prevention of recurrent respiratory infections in children: a multicentre study Int. J. Immunopathol. Pharmacol. 27 2014 413 419
18. S. Esposito, and A. Musio Immunostimulants and prevention of recurrent respiratory tract infections J. Biol. Regul. Homeost. Agents 27 2013 627 636
19. A. Licari, M. De Amici, S. Nigrisoli, A. Marseglia, S. Caimmi, and L. Artusio Pidotimod may prevent recurrent respiratory infections in children Minerva Pediatr. 66 2014 363 367
20. T. Heikkinen, and A. Järvinen The common cold Lancet 361 2003 51 59
21. D.F. Signorini Sample size for Poisson regression Biometrika 78 1991 446 450
22. J.S. Long, and J. Freese Regression Models for Categorical Dependent Variables Using Stata 3rd edition 2014 Stata Press College Station, TX
23. http://www.ecdc.europa.eu/en/publications/Publications/Influenza%20Risk%20Assessment%202014%20final.pdf (accessed 5.01.14).
24. E. Chiappini, R. Mazzantini, E. Bruzzese, A. Capuano, M. Colombo, and C. Cricelli Rational use of antibiotics for the management of children's respiratory tract infections in the ambulatory setting: an evidence-based consensus by the Italian Society of Preventive and Social Pediatrics Paediatr. Respir. Rev. 15 2014 231 236
25. European Centre for Disease Prevention and Control (ECDC) Antimicrobial Resistance Surveillance in Europe 2011. Stoccolma 2012 http://ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2013.pdf (accessed 5.04.15)